Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Design options for molecular epidemiology research within cohort studies.
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease. Dig Dis Sci. 2024 Feb; 69(2):355-359.
View in:
PubMed
subject areas
Adult
Crohn Disease
Heterocyclic Compounds, 3-Ring
Humans
Observational Studies as Topic
Remission Induction
Retrospective Studies
Treatment Outcome
Ustekinumab
authors with profiles
David Rubin